National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS): Lupus Erythematosus, Systemic trials
The registry lists 15 Lupus Erythematosus, Systemic studies with National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) as lead sponsor. 4 are open to participants now and 2 have results posted.
Early Phase 1 1Phase 1 6Phase 2 2Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Pain Phenotyping of Rheumatic Diseases - An Observational StudyNot yet recruitingNCT07829497
- Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by QuestionnairesRecruitingNCT05567198
- The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVDRecruitingNCT05440422Phase 2
- Study of Systemic Lupus ErythematosusRecruitingNCT00001372
- Genomic Effects of Glucocorticoids in Patients With Systemic Lupus ErythematosusCompletedNCT04233164Early Phase 1Results posted
- Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)CompletedNCT02338999Phase 1/2Results posted
- A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or LupusWithdrawnNCT06238531Phase 1
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus ErythematosusCompletedNCT02535689Phase 1
- Insulin Resistance and Atherosclerosis in Women With LupusCompletedNCT00544102
- Monoclonal Antibody Treatment for Systemic Lupus ErythematosusCompletedNCT00046774Phase 1
- Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus ErythematosusCompletedNCT00042523
- Positron Emission Tomography (PET) to Locate Areas of White Blood Cell ActivityCompletedNCT00029926
- Humanized LL2IGG to Treat Systemic Lupus ErythematosusCompletedNCT00011908Phase 1
- High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV CyclophosphamideCompletedNCT00005778Phase 3
- Cyclophosphamide and Fludarabine to Treat Lupus NephritisCompletedNCT00001676Phase 1